The current target customers for miRNA.DOC are health care settings where visual examinations take place and institutions where our data will be in use. In the near future, we expect the public to be our customers and use miRNA.DOC as a home-style health care gadget. Ultimately, we hope the government involves miRNA.DOC in the National Health Insurance System as an official certification for being beneficial to oral cancer detection.
There are some other AI-related assisting methods, but they are too expensive to be widely used in many countries.2 Some assisting staining methods are cheap, but they are neither quantitative nor accurate.2 Therefore, there is no assisting method for oral cancer detection that satisfies all factors at present. Launching a new assisting diagnosis that overcomes many obstacles put by the existing solutions would presumably meet the market’s need for more effective and appropriate oral cancer detection.
Oral cancer problem in Taiwan still needs to be solved:
The Health Promotion Administration provides free oral cancer screening once every two years for the people who chew betel nuts or smoke. Under this policy, 900000 people were screened each year, and about 1300 patients with oral cancer were found. However, it’s estimated that 7000 people in Taiwan get oral cancer every year.3 The executing policy is useful but not good enough to change the fact that the prevalence of oral cancer in Taiwan is higher than the global average.4 Therefore, from the government's point of view, current screening method needs to be improved.
Our products can potentially increase the rate of the people participating in the screening process because the testing process is flexible enough (please refer to the social analysis for explanation). At the same time, miRNA.DOC has the potential to possess a higher accuracy in comparison to the commonly used visual examinations due to the incorporation of 3 selected miRNA biomarkers. These two factors together can reduce the amount of undetected patients which is a favourable investment for the government.
Excessive medical expenditure:
In today's low-paying situation in Taiwan, many people work overtime, including doctors.5 Therefore, the way to reduce excessive medical spending is a big problem. However, people who have to do the biopsy after visual examinations are mostly negative, which means that a lot of resources are wasted on biopsy.6 This scenario increases the unnecessary workload as well as the costing time of the doctors and the entire process. In the end, precious medical resources are wasted.
This product allows the first-line doctors to use an accessible glucometer to evaluate the risk through a simple process, reducing the money and labour costs.
The public is not willing to do the screening:
The external reasons for the low screening rate are that the opportunity cost is too high for the general public and that the subsequent economic burdens might be heavy.7 For example, people have to sacrifice work-time to go see a doctor, especially for high-risk groups whose type of work acquires long working hours. Internally, people are afraid of biopsy because it is invasive and people are also scared to be diagnosed with oral cancer.8
In the future, miRNA.DOC will be improved to allow people to take samples at home, send them back to clinics, and even conduct self-examination at any time. The method of using it is so simple that there is no need for a professional doctor to be at present. What's more, this product only requires a saliva test, which is non-invasive for sure.
The current detection method lacks scientific backup:
Inspections highly rely on the doctor's experience and the results are not quantitative8. Also, small symptoms may not be observed by merely a peek at the oral cavity, especially when high-risk groups are not able to open their mouths wide enough (Human Practices: Sunshine Welfare Fundation). All of these may result in imprecise judgment.
Our products are quantitative and objective. It enables doctors to obtain the risk of oral cancer from the database with the use of glucometers, a product that has been standardized for a long time. Therefore, miRNA.DOC has the advantages of unified specification, low price, and wide use. It is for sure the best choice for easy quantification.
We conducted this STP Analysis mainly upon our interview with Health Promotion Administraion. They provided us valuable insights into the social-demographic segmentation of high-risk group on OSCC.
- S (Segmentation) :
- Geographic segmentation
- Country side.
- Agricultural county.
- Aboriginal tribes.
- Demographic segmentation
- Gender: male.
- Occupation: driver, worker, fisher
- Aged: middle aged (the average age is declining ).
- Psychographic segmentation
- Social class: blue collar.
- Lifestyle: chewing betel nuts, smoking.
- T (Targeting):
- The government: Health Promotion Administration can use our product to implement the National Cancer Screening Program.
- Hospitals and clinic.
- P (Positioning):
- The product which is non-invasive, quantitative and accessible for oral cancer detection.